Interstitial Lung Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with lung cancer (either small-cell or non-small-cell type), confirmed by a tissue sample test
- You have been referred for radiation treatment with the goal of curing the cancer
- You are planned to receive a radiation dose of 60–66 Gy in standard-sized sessions, though other dose plans may also be accepted depending on the treatment centre
- You may be receiving chemotherapy at the same time as your radiation treatment
- You have a small number of cancer spots that have spread to other areas, but those have already been removed or treated with radiation
- Your radiation treatment is targeting the cancer in the chest area, with the aim of curing it
- You are 18 years of age or older and have agreed to take part by signing and verbally confirming your consent
Who may not be able to join:
- You are currently receiving immunotherapy treatment at the same time as radiation
- You have had radiation treatment to your chest area in the past
- You have another cancer that is not currently under control
- You have any personal, psychological, family, social, or location-related circumstances that might make it difficult to follow the study requirements (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +61 412695410
Australian sites
+61 432207880
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
1 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Radiation-induced lung toxicity
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.